Authors:
Morisset, S
Rouleau, A
Ligneau, X
Gbahou, F
Tardivel-Lacombe, J
Stark, H
Schunack, W
Ganellin, CR
Schwartz, JC
Arrang, JM
Citation: S. Morisset et al., High constitutive activity of native H-3 receptors regulates histamine neurons in brain, NATURE, 408(6814), 2000, pp. 860-864
Authors:
Rouleau, A
Stark, H
Schunack, W
Schwartz, JC
Citation: A. Rouleau et al., Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H-3-receptor agonist prodrug, J PHARM EXP, 295(1), 2000, pp. 219-225
Authors:
Elz, S
Kramer, K
Pertz, HH
Detert, H
ter Laak, AM
Kuhne, R
Schunack, W
Citation: S. Elz et al., Histaprodifens: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H-1-receptor agonists, J MED CHEM, 43(6), 2000, pp. 1071-1084
Authors:
Stark, H
Sadek, B
Krause, M
Huls, A
Ligneau, X
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Novel histamine H-3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds, J MED CHEM, 43(21), 2000, pp. 3987-3994
Authors:
Sasse, A
Sadek, B
Ligneau, X
Elz, S
Pertz, HH
Luger, P
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., New histamine H-3-receptor ligands of the proxifan series: Imoproxifan andother selective antagonists with high oral in vivo potency, J MED CHEM, 43(17), 2000, pp. 3335-3343
Authors:
Ligneau, X
Morisset, S
Tardivel-Lacombe, J
Gbahou, F
Ganellin, CR
Stark, H
Schunack, W
Schwartz, JC
Arrang, JM
Citation: X. Ligneau et al., Distinct pharmacology of rat and human histamine H-3 receptors: role of two amino acids in the third transmembrane domain, BR J PHARM, 131(7), 2000, pp. 1247-1250
Authors:
Morini, G
Grandi, D
Stark, HB
Schunack, W
Citation: G. Morini et al., Histamine H-3-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat, BR J PHARM, 129(8), 2000, pp. 1597-1600
Authors:
Gysler, J
Mazereeuw, M
Helk, B
Heitzmann, M
Jaehde, U
Schunack, W
Tjaden, UR
van der Greef, J
Citation: J. Gysler et al., Utility of isotachophoresis-capillary zone electrophoresis, mass spectrometry and high-performance size-exclusion chromatography for monitoring of interleukin-6 dimer formation, J CHROMAT A, 841(1), 1999, pp. 63-73
Citation: J. Gysler et al., Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis, J CHROMAT B, 721(2), 1999, pp. 207-216
Authors:
Windhorst, AD
Timmerman, H
Klok, RP
Custers, FGJ
Menge, WMPB
Leurs, R
Stark, H
Schunack, W
Gielen, EGJ
van Kroonenburgh, MJPG
Herscheid, JDM
Citation: Ad. Windhorst et al., Radiosynthesis and biodistribution of I-123-labeled antagonists of the histamine H-3 receptor as potential SPECT ligands, NUCL MED BI, 26(6), 1999, pp. 651-659
Citation: J. Gysler et al., Electromigration peak dispersion of isotachophoretic protein zones during capillary zone electrophoresis, FRESEN J AN, 365(5), 1999, pp. 398-403
Authors:
Stremetzne, S
Streit, M
Kreuser, ED
Schunack, W
Jaehde, U
Citation: S. Stremetzne et al., Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer, PHARM WORLD, 21(4), 1999, pp. 184-189
Authors:
Kloft, C
Eickhoff, C
Schulze-Forster, K
Maurer, HR
Schunack, W
Jaehde, U
Citation: C. Kloft et al., Development and application of a simple assay to quantify cellular adductsof platinum complexes with DNA, PHARM RES, 16(3), 1999, pp. 470-473
Authors:
Nurnberg, B
Togel, W
Krause, G
Storm, R
Breitweg-Lehmann, E
Schunack, W
Citation: B. Nurnberg et al., Non-peptide G-protein activators as promising tools in cell biology and potential drug leads, EUR J MED C, 34(1), 1999, pp. 5-30
Authors:
Kloft, C
Appelius, H
Siegert, W
Schunack, W
Jaehde, U
Citation: C. Kloft et al., Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay, THER DRUG M, 21(6), 1999, pp. 631-637
Authors:
Morini, G
Grandi, D
Bertaccini, G
Leschke, C
Schunack, W
Citation: G. Morini et al., Stereoselective inhibition of ethanol-induced gastric lesions in the rat by the H-3-receptor agonist (R)-alpha-methylhistamine and its (S)-configuredisomer, PHARMACOL, 59(4), 1999, pp. 192-200
Authors:
Malinowska, B
Piszcz, J
Schlicker, E
Kramer, K
Elz, S
Schunack, W
Citation: B. Malinowska et al., Histaprodifen, methylhistaprodifen, and dimethylhistaprodifen are potent H-1-receptor agonists in the pithed and in the anaesthetized rat, N-S ARCH PH, 359(1), 1999, pp. 11-16
Authors:
Sasse, A
Kiec-Kononowicz, K
Stark, H
Motyl, M
Reidemeister, S
Ganellin, CR
Ligneau, X
Schwartz, JC
Schunack, W
Citation: A. Sasse et al., Development of chiral N-alkylcarbamates as new leads for potent and selective H-3-receptor antagonists: Synthesis, capillary electrophoresis, and in vitro and oral in vivo activity, J MED CHEM, 42(4), 1999, pp. 593-600
Authors:
Sasse, A
Stark, H
Reidemeister, S
Huls, A
Elz, S
Ligneau, X
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: A. Sasse et al., Novel partial agonists for the histamine H-3 receptor with high in vitro and in vivo activity, J MED CHEM, 42(20), 1999, pp. 4269-4274
Authors:
Kathmann, M
Schlicker, E
Marr, L
Werthwein, S
Stark, H
Schunack, W
Citation: M. Kathmann et al., Ciproxifan and chemically related compounds are highly potent and selective histamine H-3-receptor antagonists, N-S ARCH PH, 358(6), 1998, pp. 623-627